According to research by nova one advisor, the global cell and gene therapy market size was valued at $18.13 billion in 2023 ...

Trenchant partnered with Autolomous, integrating its digital solution into its CGT manufacturing platform, for faster production and lower costs.

Cell therapy production processes tend to evolve as the ... “One of the technical challenges during scale up is that the process developed to manufacture trial supplies is almost always ...

The CAR-NK cell production process also avoids the variability seen in cell therapy products when the starting cells originate from a unique donor each time. To assess the safety of off-the-shelf ...

The CAR-NK cell production process also avoids the variability seen in cell therapy products when the starting cells originate from a unique donor each time. To assess the safety of off-the-shelf ...

CDMO Rentschler Biopharma is signalling its intent to cut down cell and gene therapy operations by shutting down its UK ...